# Tolvaptan for Ascites in Cirrhotic Patients

> **NCT01292304** · PHASE4 · COMPLETED · sponsor: **University of Florida** · enrollment: 10 (actual)

## Conditions studied

- Ascites
- Cirrhosis

## Interventions

- **DRUG:** Tolvaptan

## Key facts

- **NCT ID:** NCT01292304
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2014-12
- **Final completion:** 2015-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2015-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01292304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01292304, "Tolvaptan for Ascites in Cirrhotic Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01292304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*